Global Mice Model Market Size USD 2.78 Billion in 2032 | Emergen Research


Increasing investments in research and development activities in the pharmaceutical & biotechnology sector and increasing use of mice model for personalized drug production are driving the mice model market.

Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global mice model market is projected to reach USD 2.78 Billion by 2032, according to a current analysis by Emergen Research. Due to increasing utilization of mice models for personalized drug production, the global mice model market is likely to expand rapidly during the forecast period. Besides, increasing investments in research and development activities in the pharmaceutical & biotechnology sector is another factor expected to augment the global mice model market during the forecast period. Moreover, the rising use of mice models in the production of monoclonal antibodies is likely to fuel the global mice model market during the forecast period.

However, during the forecast period, the global mice model market is expected to be restrained by the continuous discovery of substitute approaches for animal studies.


Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Segments Covered in Report

Report Details Outcome
The market size in 2019 USD 1.22 Billion
CAGR (2023–2032) 6.8%
The revenue forecast in 2032 USD 2.78 Billion
Base year for estimation 2019
Historical data 2016–2018
Forecast period 2023–2032
Quantitative units Volume in tons, revenue in USD Billion, and CAGR from 2023 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, service, technology, application, end-use, and region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope U.S.; Canada; Mexico; U.K.; Germany; France; BENELUX; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiled Envigo Ltd, TransViragen Inc., Charles River Laboratories International Inc., GenOway S.A., The Jackson Laboratory, Ozgene Pty Ltd, GVK Biosciences Private Limited, Taconic Biosciences Inc., Pharmaron, Inc., Horizon Discovery Group plc
Customization scope 10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

MAJOR COMPANIES and Market Share Analysis

The global market for mice models is consolidated, with a few large- and medium-sized players accounting for a significant share of the global market. Some of the top players in the mice model market are:

    • Envigo Ltd
    • TransViragen Inc.
    • Charles River Laboratories International Inc.
    • GenOway S.A.
    • The Jackson Laboratory
    • Ozgene Pty Ltd
    • GVK Biosciences Private Limited
    • Taconic Biosciences, Inc.
    • Pharmaron, Inc.
    • Horizon Discovery Group plc

Strategic Development

  • In January 2020, HemaCare Corporation was acquired by Charles River Laboratories International Inc. The inclusion of cellular products from HemaCare would increase Charles River Laboratories’ capability to offer a holistic approach for cell therapy from development to commercialization, which would increase the efficiency of consumers. The deal of HemaCare is a core part of the plan to completely support the initial drug discovery activities of Charles River Laboratories fulfill the lengthy growth targets, and increase shareholders’ value.
  • In November 2020, Absorption Systems LP was acquired by Pharmaron, Inc. This deal would boost the fully integrated, end-to-end drug research & development facilities of Pharmaron globally.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

Key Highlights of Report

  • In February 2020, The Jackson Laboratory introduced the K18-hACE2 transgenic mouse to help in COVID-19 research activities with mice models
  • During the forecast period, the knockout segment is expected to expand substantially. Use of knockout mice in the study offers several benefits, for example, impact of the target gene can be minimized without any of the adverse effects of drugs and the genome can be modified to determine the essential role of several endogenous variables in behavior. This factor is anticipated to fuel the segment in the near future.
  • During the forecast period, the genetic testing segment is projected to expand at a sluggish pace of 6.9%. In genetic research and clinical studies of different human diseases, mice are often used, as the mouse genome is highly similar to that of humans.
  • Due to the reliable execution of microinjection technology, the microinjection segment is expected to expand significantly throughout the forecast period, increasing the possibilities for an integrative shift. Mini-structures comprising just a few cells and with high restorative capacity can be delivered. Since it is a direct physical solution, it is completely independent of the host range.
  • During the forecast period, the infectious diseases segment is expected to expand substantially. With the use of mice models, groups of researchers can explore how pathogens initiate infections, determine the role of certain host genes in either disease prevention or mitigation, and identify potential targets for the control and diagnosis of a spectrum of contagious diseases.
  • Due to growth of the biotechnology industry in developing countries, the Asia Pacific market is expected to register the most rapid growth rate during the forecast period

Browse Full Report Description + Research Methodology + Table of Content + Infographics@
Emergen Research has segmented the global mice model market on the basis of type, service, technology, application, end-use, and region.

  • Type Outlook (Revenue, USD Billion; 2023–2032)
    • Outbred
    • Hybrid
    • Inbred
    • Knockout
    • Spontaneous Mutant
  • Service Outlook (Revenue, USD Billion; 2023–2032)
    • Cryopreservation
    • Rederivation
    • Genetic Testing
    • Breeding
    • Quarantine
    • Others
  • Technology Outlook (Revenue, USD Billion; 2023–2032)
    • CRISPR
    • Nuclear Transfer
    • Embryonic Stem Cell Injection
    • Microinjection
    • Others
  • Application Outlook (Revenue, USD Billion; 2023–2032)
    • Cancer
    • Diabetes
    • Research & Development
    • Academics
    • Cardiovascular Studies
    • Genetic Studies
    • Infectious Diseases
    • Neurological Diseases
    • Others
  • End-use Outlook (Revenue, USD Billion; 2023–2032)
    • Pharmaceutical
    • Cosmetics
    • Biotechnology
    • Government
    • Contract Research Organizations
    • Academic & Research Institutes
    • Others
  • Regional Outlook (Revenue, USD Billion; 2023–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Tissue Imaging Market By Technology, By Products, By Application, By End-Users, Forecasts to 2027

Medical Devices Testing Services Market By Phase (Clinical, Preclinical), By Service (Chemistry Test, Package Validation, Microbiology & Sterility Testing, Biocompatibility Tests), Forecasts to 2027

Hematologic Malignancies Testing Market By Product (Services, Kits), By Technology (Polymerase Chain Reaction, Immunohistochemistry, Next-generation sequencing, Fluorescence in situ hybridization), By Disease, By End-Use, By Region Forecasts to 2027

Industrial Microbiology Market By Product (Reaction Consumables, Laboratory Supply, Equipment & Systems), By Type (Microbial Limit Testing, Sterility Testing, and Others), By End-Use (Food & Beverages, Pharmaceuticals & Biotechnology, Agriculture, Others), By Region Forecasts to 2027

Blockchain in Genomics Market By Service, By Business Model, By Application (Data Storage & Security, Data Sharing and Monetization, Automated Health Insurance), By End-Use (Hospitals, Pharmaceutical and Biotechnology, Research Institutes), By Region Forecasts to 2027

Prenatal Testing Market By Method, Test-Type (Invasive, Non-Invasive) By Application (Microdeletions Symptoms, Trisomy, Others), By End-Use (Specialty Clinics, Hospitals, Diagnostic Centers), By Region Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Explore Our Japanese Version: Mice Model Market

Explore Our Blogs and Insights Section:

Read our Press Release @

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.